EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
1 clinical trials · Condition
◉ Watch EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor
| Record | Firm | Date |
|---|---|---|
| A Study of Almonertinib Combined With Palbociclib in Patients With Advanced Solid Tumors Harboring KRAS Mutations (NCT06947811) | Sun Yat-sen University | 2025-06-09 |
Track EGFR Tyrosine Kinase Inhibitors Plus Cyclin-dependent Kinase 4/6 Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.